Biotech might be the hottest -- and most volatile -- sector going, and the Biogen-Idec hook-up announced this morning could get these names moving again.
To help you navigate this trickiest of sectors, Adam Feuerstein covers the biotech beat for
, and on Wednesday, June 25 he will host an interactive chat and discuss the five things you need to know before you buy a biotech stock -- and perhaps give you some insight into other possible corporate pairings in the future.
After Adam gives you his list, he'll answer as many of your questions as he can. (If you can't make the 1 p.m. EDT chat, you can always sign up, submit your questions before the chat starts, and read the transcript later.)
for more information about the chat and to sign up.
Editor in Chief
David Morrow is editor-in-chief of TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He welcomes your feedback and invites you to send it to